CUSIP 61225M102COMGLUEQ4 2025
48 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nea Management Company, LLC | 7.69M | $120.62M |
| 2 | Tcg Crossover Management, LLC | 4.62M | $72.48M |
| 3 | Versant Venture Management, LLC | 4.38M | $68.72M |
| 4 | Baker Bros. Advisors LP | 4.35M | $68.14M |
| 5 | Blackrock, Inc. | 4.18M | $65.56M |
| 6 | Bvf Inc/Il | 3.84M | $60.15M |
| 7 | Suvretta Capital Management, LLC | 3.36M | $52.68M |
| 8 | Vanguard Group Inc | 3.25M | $50.91M |
| 9 |
| 4 | Jan 9, 2026 | Versant Venture Capital Vi, L.P. | 13D/A | 3.4% | — | SEC |
| 5 | Nov 14, 2025 | Avoro Capital Advisors LLC | 13G/A | — | 49 | SEC |
| 6 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 7.5% | 4.64M | SEC |
| 7 | Nov 12, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 5.1% | — | SEC |
| 8 | Oct 31, 2025 | The Vanguard Group | 13G/A | 4.8% | 2.99M | SEC |
| 9 | Oct 17, 2025 | Tcg Crossover Gp II, LLC | 13G | 11.0% | 4.43M | SEC |
| 10 | Oct 3, 2025 | Adam Goulburn | 13G | 7.7% | 4.76M | SEC |
See the full Schedule 13D/13G history for Monte Rosa Therapeutics Inc.
Unlock full history| State Street Corp |
| 2.11M |
| $33.05M |
| 10 | Aisling Capital Management LP | 1.47M | $23.09M |